Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Ultrahigh-mobility graphene devices from chemical vapor deposition on reusable copper.

Banszerus L, Schmitz M, Engels S, Dauber J, Oellers M, Haupt F, Watanabe K, Taniguchi T, Beschoten B, Stampfer C.

Sci Adv. 2015 Jul 31;1(6):e1500222. doi: 10.1126/sciadv.1500222. eCollection 2015 Jul.

2.

Multiparametric imaging of patient and tumour heterogeneity in non-small-cell lung cancer: quantification of tumour hypoxia, metabolism and perfusion.

van Elmpt W, Zegers CML, Reymen B, Even AJG, Dingemans AC, Oellers M, Wildberger JE, Mottaghy FM, Das M, Troost EGC, Lambin P.

Eur J Nucl Med Mol Imaging. 2016 Feb;43(2):240-248. doi: 10.1007/s00259-015-3169-4. Epub 2015 Sep 4.

3.

A qualitative synthesis of the evidence behind elective lymph node irradiation in oesophageal cancer.

Van De Voorde L, Larue RT, Pijls M, Buijsen J, Troost EG, Berbée M, Sosef M, van Elmpt W, Schraepen MC, Vanneste B, Oellers M, Lambin P.

Radiother Oncol. 2014 Nov;113(2):166-74. doi: 10.1016/j.radonc.2014.11.010. Epub 2014 Nov 25. Review.

PMID:
25465727
4.

Prognostic value of metabolic metrics extracted from baseline positron emission tomography images in non-small cell lung cancer.

Carvalho S, Leijenaar RT, Velazquez ER, Oberije C, Parmar C, van Elmpt W, Reymen B, Troost EG, Oellers M, Dekker A, Gillies R, Aerts HJ, Lambin P.

Acta Oncol. 2013 Oct;52(7):1398-404. doi: 10.3109/0284186X.2013.812795. Epub 2013 Sep 9.

5.

Individualised isotoxic accelerated radiotherapy and chemotherapy are associated with improved long-term survival of patients with stage III NSCLC: a prospective population-based study.

De Ruysscher D, van Baardwijk A, Steevens J, Botterweck A, Bosmans G, Reymen B, Wanders R, Borger J, Dingemans AM, Bootsma G, Pitz C, Lunde R, Geraedts W, Oellers M, Dekker A, Lambin P.

Radiother Oncol. 2012 Feb;102(2):228-33. doi: 10.1016/j.radonc.2011.10.010. Epub 2011 Nov 17.

PMID:
22100659
6.

Accurate automatic delineation of heterogeneous functional volumes in positron emission tomography for oncology applications.

Hatt M, Cheze le Rest C, Descourt P, Dekker A, De Ruysscher D, Oellers M, Lambin P, Pradier O, Visvikis D.

Int J Radiat Oncol Biol Phys. 2010 May 1;77(1):301-8. doi: 10.1016/j.ijrobp.2009.08.018. Epub 2010 Jan 29.

7.

Selective nodal irradiation on basis of (18)FDG-PET scans in limited-disease small-cell lung cancer: a prospective study.

van Loon J, De Ruysscher D, Wanders R, Boersma L, Simons J, Oellers M, Dingemans AM, Hochstenbag M, Bootsma G, Geraedts W, Pitz C, Teule J, Rhami A, Thimister W, Snoep G, Dehing-Oberije C, Lambin P.

Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):329-36. doi: 10.1016/j.ijrobp.2009.04.075. Epub 2009 Sep 24.

PMID:
19782478
8.

Comparison between perfusion computed tomography and dynamic contrast-enhanced magnetic resonance imaging in rectal cancer.

Kierkels RG, Backes WH, Janssen MH, Buijsen J, Beets-Tan RG, Lambin P, Lammering G, Oellers MC, Aerts HJ.

Int J Radiat Oncol Biol Phys. 2010 Jun 1;77(2):400-8. doi: 10.1016/j.ijrobp.2009.05.015. Epub 2009 Sep 3.

PMID:
19733445
9.

Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)Fluorodeoxyglucose-PET-CT scan.

Aerts HJ, van Baardwijk AA, Petit SF, Offermann C, Loon Jv, Houben R, Dingemans AM, Wanders R, Boersma L, Borger J, Bootsma G, Geraedts W, Pitz C, Simons J, Wouters BG, Oellers M, Lambin P, Bosmans G, Dekker AL, De Ruysscher D.

Radiother Oncol. 2009 Jun;91(3):386-92. doi: 10.1016/j.radonc.2009.03.006. Epub 2009 Mar 28.

10.

Follow-up with 18FDG-PET-CT after radical radiotherapy with or without chemotherapy allows the detection of potentially curable progressive disease in non-small cell lung cancer patients: a prospective study.

van Loon J, Grutters J, Wanders R, Boersma L, Oellers M, Dingemans AM, Bootsma G, Geraedts W, Pitz C, Simons J, Fatah SA, Snoep G, Hochstenbag M, Lambin P, De Ruysscher D.

Eur J Cancer. 2009 Mar;45(4):588-95. doi: 10.1016/j.ejca.2008.10.017. Epub 2008 Dec 4.

PMID:
19046631
11.

Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?

Vliegen RF, Beets-Tan RG, Vanhauten B, Driessen A, Oellers M, Kessels AG, Arens A, Beets GL, Buijsen J, van Baardwijk A, de Ruysscher D, Lammering G.

Strahlenther Onkol. 2008 Sep;184(9):457-64. doi: 10.1007/s00066-008-1858-7. Epub 2008 Sep 19.

PMID:
19016024
12.

18FDG-PET based radiation planning of mediastinal lymph nodes in limited disease small cell lung cancer changes radiotherapy fields: a planning study.

van Loon J, Offermann C, Bosmans G, Wanders R, Dekker A, Borger J, Oellers M, Dingemans AM, van Baardwijk A, Teule J, Snoep G, Hochstenbag M, Houben R, Lambin P, De Ruysscher D.

Radiother Oncol. 2008 Apr;87(1):49-54. doi: 10.1016/j.radonc.2008.02.019. Epub 2008 Mar 14.

PMID:
18342967
13.

Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study.

Aerts HJ, Bosmans G, van Baardwijk AA, Dekker AL, Oellers MC, Lambin P, De Ruysscher D.

Int J Radiat Oncol Biol Phys. 2008 Aug 1;71(5):1402-7. doi: 10.1016/j.ijrobp.2007.11.049. Epub 2008 Jan 30.

PMID:
18234432
14.

Short-term estradiol treatment enhances pituitary-adrenal axis and sympathetic responses to psychosocial stress in healthy young men.

Kirschbaum C, Schommer N, Federenko I, Gaab J, Neumann O, Oellers M, Rohleder N, Untiedt A, Hanker J, Pirke KM, Hellhammer DH.

J Clin Endocrinol Metab. 1996 Oct;81(10):3639-43.

PMID:
8855815

Supplemental Content

Loading ...
Support Center